Virtus AllianzGI Dividend Interest & Premium Strategy Fund Vs. Rapt Therapeutics, Inc. Industry Stock Comparison

Buy

59

NFJ
Virtus AllianzGI Dividend Interest & Premium Strategy Fund

Last Price:

$12.86

Seasonality Move:

0.43%

Sell

38

RAPT
Rapt Therapeutics, Inc.

Last Price:

$33.91

Seasonality Move:

-28.15%

Buy

59

Virtus AllianzGI Dividend Interest & Premium Strategy Fund (NFJ) is a Buy

Is Virtus AllianzGI Dividend Interest & Premium Strategy Fund a Buy, Sell or Hold?

The current Virtus AllianzGI Dividend Interest & Premium Strategy Fund [NFJ] share price is $12.94. The Score for NFJ is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
NFJ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

38

Rapt Therapeutics, Inc. (RAPT) is a Sell

Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?

The current Rapt Therapeutics, Inc. [RAPT] share price is $33.38. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NFJ Stock Price Chart

What is Virtus AllianzGI Dividend Interest & Premium Strategy Fund's stock price today?

The Virtus AllianzGI Dividend Interest & Premium Strategy Fund share price today is $12.94

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NFJ is experiencing slight selling pressure.

RAPT Stock Price Chart

What is Rapt Therapeutics, Inc.'s stock price today?

The Rapt Therapeutics, Inc. share price today is $33.38

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing selling pressure, which indicates risk of future bearish movement.

NFJ Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0	Sell
Relative Strength Index (14 RSI):	53.27	Buy
Chaikin Money Flow:	-83316	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(12.71 - 13.09)	Buy
Bollinger Bands (100):	(12.72 - 13.06)	Buy

RAPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	9.71	Buy
Relative Strength Index (14 RSI):	49.51	Sell
Chaikin Money Flow:	-220916	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(32.11 - 35.93)	Sell
Bollinger Bands (100):	(16.49 - 33.77)	Buy

NFJ Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	12.83	Buy
20-day SMA:	12.93	Buy
50-day SMA:	12.87	Buy
200-day SMA:	12.48	Buy
8-day EMA:	12.88	Buy
20-day EMA:	12.88	Buy
50-day EMA:	12.88	Buy
200-day EMA:	12.69	Buy

RAPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	35.03	Sell
20-day SMA:	34.65	Sell
50-day SMA:	31.71	Buy
200-day SMA:	16.89	Buy
8-day EMA:	31.26	Buy
20-day EMA:	20.72	Buy
50-day EMA:	10.54	Buy
200-day EMA:	3	Buy

Virtus AllianzGI Dividend Interest & Premium Strategy Fund Earnings Growth & NFJ Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.

Virtus AllianzGI Dividend Interest & Premium Strategy Fund Technical Analysis

	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 24	Dec 26	Dec 29	Dec 30
	Dec
	15	16	17	18	19	22	24	26	29	30
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rapt Therapeutics, Inc. Technical Analysis

	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 23	Dec 24	Dec 26	Dec 29	Dec 30
	Dec
	16	17	18	19	22	23	24	26	29	30
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):